Patent 11566276

Litigation summary

Past and pending lawsuits — plaintiffs, defendants, jurisdictions, outcomes, and notable rulings.

Active provider: Google · gemini-2.5-pro

No PTAB proceedings on file. This patent has not been challenged through Inter Partes Review, Post-Grant Review, or Covered Business Method review at the USPTO. The absence is itself a signal — well-asserted patents eventually attract IPRs.

Cases on file (1)

Group view →

Specific litigation cases in our database that name US patent 11566276. The free-form analysis below may also discuss cases beyond this list.

Litigation summary

Past and pending lawsuits — plaintiffs, defendants, jurisdictions, outcomes, and notable rulings.

✓ Generated

Litigation History of U.S. Patent 11,566,276

As of May 12, 2026, research of court records and legal news databases indicates one known litigation case involving U.S. Patent No. 11,566,276. Details of this case are provided below.

Case 1

  • Case Name: 10X Genomics, Inc. and President and Fellows of Harvard College v. Element Biosciences, Inc.
  • Plaintiffs:
  • Defendant: Element Biosciences, Inc.
  • Jurisdiction: U.S. District Court for the District of Delaware
  • Case Number: 1:2026cv00538
  • Filing Date: May 8, 2026
  • Status: Active/Ongoing. The complaint was recently filed.
  • Summary of Allegations: The plaintiffs allege that Element Biosciences' AVITI24 platform and Teton chemistry infringe upon four patents, including U.S. Patent 11,566,276. The technology in question relates to methods for detecting and analyzing biological signals within cells and tissues. The plaintiffs are seeking a permanent injunction or future royalties, in addition to damages for past infringement. Element Biosciences has publicly stated that it "strongly disagrees with the allegations" and will "vigorously defend its technology."

No other litigation involving US patent 11,566,276 was identified in this search.

Generated 5/12/2026, 6:48:37 AM